184 related articles for article (PubMed ID: 32124317)
1. OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction.
Kodysh J; Rubinsteyn A
Methods Mol Biol; 2020; 2120():147-160. PubMed ID: 32124317
[TBL] [Abstract][Full Text] [Related]
2. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
3. In Silico Prediction of Tumor Neoantigens with TIminer.
Kirchmair A; Finotello F
Methods Mol Biol; 2020; 2120():129-145. PubMed ID: 32124316
[TBL] [Abstract][Full Text] [Related]
4. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
Schäfer RA; Guo Q; Yang R
Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
[TBL] [Abstract][Full Text] [Related]
5. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
[TBL] [Abstract][Full Text] [Related]
6. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
[TBL] [Abstract][Full Text] [Related]
7. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
Lancaster EM; Jablons D; Kratz JR
Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
[TBL] [Abstract][Full Text] [Related]
8. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
Zhang J; Mardis ER; Maher CA
Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
[TBL] [Abstract][Full Text] [Related]
9. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.
Hundal J; Kiwala S; McMichael J; Miller CA; Xia H; Wollam AT; Liu CJ; Zhao S; Feng YY; Graubert AP; Wollam AZ; Neichin J; Neveau M; Walker J; Gillanders WE; Mardis ER; Griffith OL; Griffith M
Cancer Immunol Res; 2020 Mar; 8(3):409-420. PubMed ID: 31907209
[TBL] [Abstract][Full Text] [Related]
10. Best practices for bioinformatic characterization of neoantigens for clinical utility.
Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
[TBL] [Abstract][Full Text] [Related]
11. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
[TBL] [Abstract][Full Text] [Related]
12. NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline.
Schenck RO; Lakatos E; Gatenbee C; Graham TA; Anderson ARA
BMC Bioinformatics; 2019 May; 20(1):264. PubMed ID: 31117948
[TBL] [Abstract][Full Text] [Related]
13. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction.
Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923
[TBL] [Abstract][Full Text] [Related]
14. Methods behind neoantigen prediction for personalized anticancer vaccines.
Godazandeh K; Van Olmen L; Van Oudenhove L; Lefever S; Bogaert C; Fant B
Methods Cell Biol; 2024; 183():161-186. PubMed ID: 38548411
[TBL] [Abstract][Full Text] [Related]
15. Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data.
Alburquerque-González B; López-Abellán MD; Luengo-Gil G; Montoro-García S; Conesa-Zamora P
Methods Mol Biol; 2022; 2547():165-185. PubMed ID: 36068464
[TBL] [Abstract][Full Text] [Related]
16. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.
Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB
Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193
[TBL] [Abstract][Full Text] [Related]
17. Integrated protocol for exitron and exitron-derived neoantigen identification using human RNA-seq data with ScanExitron and ScanNeo.
Wang TY; Yang R
STAR Protoc; 2021 Sep; 2(3):100788. PubMed ID: 34522901
[TBL] [Abstract][Full Text] [Related]
18. AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.
Wünsch C; Banck H; Müller-Tidow C; Dugas M
BMC Med Genomics; 2020 Feb; 13(1):17. PubMed ID: 32019565
[TBL] [Abstract][Full Text] [Related]
19. Proteogenomic Platform for Identification of Tumor Specific Antigens.
Faktor J; Hernychová L; Vojtěšek B; Hupp T
Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032
[TBL] [Abstract][Full Text] [Related]
20. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]